Clinical Trial Update: Mesalazine and/or Lactobacillus Casei in the Diverticular Disease of the Colon [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating mesalazine and/or Lactobacillus casei for diverticular disease of the colon has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diverticular Disease of the Colon

Drugs mentioned

• Lactobacillus casei (Lactobacillus casei)
• Mesalazine (mesalazine)

Snippet

Sponsor: Hospital Cristo Re | Conditions: Diverticular Disease of the Colon | Phase 4 | Status: COMPLETED